RxDoctor Payments Data

Philip Mar

Clinical Cardiac Electrophysiology · Saint Louis, MONPI 1982999462

Payments from drug & device makers

What this record shows

23 manufacturers reported payments, led by Medtronic at 41.1% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in MO, where the typical reported total is $14,594.

$12,457in general payments, 2019–2025

Across 161 payments — averaging $77.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Abbott$3K
  • Boston Scientific$2K
  • Biosense Webster, Inc.$996
  • Atricure, Inc.$192
  • Cook Medical LLC$189
  • plus $1K from 17 others
$54,037in research payments, 2019–2025

Across 14 payments — averaging $3859.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$54K

What the payments were for

  • Travel & lodging$6,74454%
  • Food & beverage$5,71346%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,457 in reported general payments places this provider in the 45th percentile of 74 clinical cardiac electrophysiology providers in Missouri.

See all clinical cardiac electrophysiology providers in Missouri

Medicare billing

Part B allowed, 2024
$152,413
Medicare patients
961
Services billed
2,125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban177$230,393
XareltoRivaroxaban79$89,069
EntrestoSacubitril/Valsartan16$24,149
Dofetilide88$19,893
Metoprolol Succinate203$2,572
Midodrine Hcl17$1,543
Flecainide Acetate54$1,487
Diltiazem 24hr Er (Cd)Diltiazem Hcl33$1,380
Mexiletine Hcl11$1,362
Amiodarone Hcl64$797
Diltiazem 24hr ErDiltiazem Hcl23$704
Atorvastatin Calcium81$652
Losartan Potassium40$527
Carvedilol68$441
Spironolactone39$435

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$150$230,393177 claims
Johnson & JohnsonXarelto$26$89,06979 claims
NovartisEntresto$69$24,14916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 74 clinical cardiac electrophysiology providers in Missouri.

Other clinical cardiac electrophysiology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →